Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial

被引：3

作者：

Correll, Christoph U. ^{[1
,2
,3
]}

Miller, Andrew C. ^{[4
]}

Sawchak, Sharon ^{[4
]}

Kaul, Inder ^{[4
]}

Paul, Steven M. ^{[4
]}

Brannan, Stephen K. ^{[4
]}

机构：

[1] Zucker Hillside Hosp, Glen Oaks, NY USA

[2] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Karuna Therapeut, Boston, MA USA

来源：

CNS SPECTRUMS | 2023年 / 28卷 / 02期

关键词：

D O I：

10.1017/S1092852923001360

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：220 / 220

页数：1

共 50 条

[31] Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial
Ogata, Hiroaki
Shimofurutani, Naoko
Okada, Tadashi
Nagamoto, Hisashi
Akizawa, Tadao
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1088 - 1097
[32] Efficacy and Safety of Telitacicept in Primary Sjogren's Syndrome: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial
Xu, Dong
Zhang, Shangzhu
Huang, Cibo
Huang, Chenghui
Qin, Li
Li, Xiaomei
Chen, Meiqing
Liu, Xiumei
Liu, Yi
Li, Zhijun
Hu, Jiankang
Bao, Chunde
Wei, Wei
Tian, Jing
Duan, Xinwang
Fang, Jianmin
Zeng, Xiaofeng
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4002 - 4004
[33] Efficacy and safety of telitacicept in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
Xu, Dong
Fang, Jianmin
Zhang, Shangzhu
Huang, Cibo
Huang, Chenghui
Qin, Li
Li, Xiaomei
Chen, Meiqing
Liu, Xiumei
Liu, Yi
Li, Zhijun
Hu, Jiankang
Bao, Chunde
Wei, Wei
Tian, Jing
Duan, Xinwang
Zeng, Xiaofeng
RHEUMATOLOGY, 2024, 63 (03) : 698 - 705
[34] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
Chowla, Navreet M.
Tariq, Raseen
Aggarwal, Manik
Loftus, Edward V.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
[35] Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies
Weiss, C.
Zhang, P.
Hakala, M. J.
Skuban, A.
Weiller, E.
EUROPEAN PSYCHIATRY, 2016, 33 : S109 - S109
[36] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Zhang, Bo
Cheng, Zhifeng
Chen, Ji
Zhang, Xin
Liu, Dexue
Jiang, Hongwei
Ma, Guoqing
Wang, Xiaoyun
Gan, Shenglian
Sun, Juan
Jin, Ping
Yi, Jianjun
Shi, Bimin
Ma, Jianhua
Ye, Shandong
Wang, Guixia
Ji, Linong
Gu, Xuejiang
Yu, Ting
An, Pei
Deng, Huan
Li, Haoyu
Li, Li
Ma, Qingyang
Qian, Lei
Yang, Wenying
DIABETES CARE, 2024, 47 (01) : 160 - 168
[37] Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
Correll, Christoph U.
Skuban, Aleksandar
Ouyang, John
Hobart, Mary
Pfister, Stephanie
McQuade, Robert D.
Nyilas, Margaretta
Carson, William H.
Sanchez, Raymond
Eriksson, Hans
AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (09): : 870 - 880
[38] Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
Vicari, RM
Chaitman, B
Keefe, D
Smith, WB
Chrysant, SG
Tonkon, MJ
Bittar, N
Weiss, RJ
Morales-Ballejo, H
Thadani, U
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1803 - 1811
[39] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
Biton, V
Rosenfeld, W
Schachter, S
Perdomo, C
Arroyo, S
ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
[40] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
Thase, Michael E.
Mathews, Maju
Forero, Giovanna
Nunez, Rene
Chen, Changzheng
Gommoll, Carl
Durgam, Suresh
NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344

← 1 2 3 4 5 →